Subbu Nambi
Stock Analyst at Guggenheim
(4.70)
# 142
Out of 5,090 analysts
53
Total ratings
67.44%
Success rate
24.23%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.06 | - | 4 | Nov 21, 2025 | |
| GRAL GRAIL | Upgrades: Buy | $100 | $100.98 | -0.97% | 2 | Nov 12, 2025 | |
| PSNL Personalis | Maintains: Buy | $6 → $12 | $9.56 | +25.52% | 1 | Nov 11, 2025 | |
| VCYT Veracyte | Maintains: Buy | $40 → $45 | $44.61 | +0.87% | 4 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $115 → $170 | $158.96 | +6.95% | 2 | Oct 29, 2025 | |
| RVTY Revvity | Initiates: Neutral | n/a | $100.79 | - | 1 | Oct 16, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $20 | $14.75 | +35.59% | 1 | Sep 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $76.66 | +23.92% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $102.02 | -34.33% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $28.86 | +24.74% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $226.25 | +10.50% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.98 | +67.22% | 3 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $114 | $128.96 | -11.60% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $32.30 | +54.80% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.54 | +4.82% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.09 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $48.03 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $244.55 | -18.22% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.85 | +23.71% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.03 | +196.30% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.77 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $164.98 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $38.65 | -35.32% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.39 | - | 1 | Dec 14, 2023 |
Exact Sciences
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.06
Upside: -
GRAIL
Nov 12, 2025
Upgrades: Buy
Price Target: $100
Current: $100.98
Upside: -0.97%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $6 → $12
Current: $9.56
Upside: +25.52%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $44.61
Upside: +0.87%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $158.96
Upside: +6.95%
Revvity
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $100.79
Upside: -
Adaptive Biotechnologies
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $14.75
Upside: +35.59%
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $76.66
Upside: +23.92%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $102.02
Upside: -34.33%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $28.86
Upside: +24.74%
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $226.25
Upside: +10.50%
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.98
Upside: +67.22%
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $128.96
Upside: -11.60%
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $32.30
Upside: +54.80%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.54
Upside: +4.82%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.09
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $48.03
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $244.55
Upside: -18.22%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.85
Upside: +23.71%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $2.03
Upside: +196.30%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $17.77
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $164.98
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $38.65
Upside: -35.32%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.39
Upside: -